Distributed under the brand names Geref and Geref Diagnostic, it gained FDA approval in 1997 as a treatment for growth hormone deficiency but was discontinued in 2008 not out of concern for safety or lack of efficacy, but because of manufacturing difficulties.2 3 Yet it remains available in compounded form with a prescription from a licensed healthcare provider
Pharmakologische Risikoanalyse zu "Injectable Peptides" (BPC-157, Melanotan) Pharmazeutische Warnung & Aufklrung | Stand: Januar 2026 Status: Beliebte Peptide wie BPC-157 oder Melanotan II haben keine Zulassung als Humanarzneimittel
High Purity (99%): Ensures consistency and reliability in experimental results
Wang H, Li L, Qin LL, Song Y, Vidal-Alaball J, Liu TH
Nutrition (Burbank, Los Angeles County, Calif)
He reviews your injury history, current medications, labs if indicated, and treatment goals, then builds a protocol around your specific situation